STOCK TITAN
  1. Home
  2. Financials
  3. ESPR
  4. Revenue

Esperion Therapeutics, Inc. (ESPR) Revenue by Year

ESPR

Esperion Therapeutics, Inc. generated $403.1M in revenue in fiscal year 2025. This represents an increase of 21.3% from the prior fiscal year. Over the trailing 12 months, Q2 FY2025 through Q1 FY2026, the same line adds up to $418.2M in revenue. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Esperion Therapeutics, Inc. has filed alongside them.

FY2025 annual
Revenue $403.1M
YoY +21.3%
5Y CAGR +12.1%
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ESPR Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Revenue$418.2M$403.1M+21.3%$332.3M+185.7%$116.3M+54.1%$75.5M-3.8%$78.4M-65.5%$227.5M+53.4%$148.4M$0N/AN/AN/AN/AN/AN/AN/A

TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.

ESPR Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-Q
Revenue$80.1M+23.2%$168.4M+143.7%$87.3M+69.1%$82.4M+11.6%$65.0M-52.8%$69.1M+114.3%$51.6M+52.0%$73.8M+186.3%$137.7M+466.1%$32.3M+71.4%$34.0M+79.0%$25.8M+36.9%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Esperion Therapeutics, Inc. financials

Frequently Asked Questions

What was Esperion Therapeutics, Inc.'s revenue in fiscal year 2025?

Esperion Therapeutics, Inc. generated $403.1M in revenue in fiscal year 2025.

How fast is Esperion Therapeutics, Inc.'s revenue growing?

Esperion Therapeutics, Inc. (ESPR) revenue rose by 21.3% year over year, from $332.3M to $403.1M in fiscal year 2025.

What is Esperion Therapeutics, Inc.'s revenue over the last twelve months?

Esperion Therapeutics, Inc. (ESPR) reported $418.2M in revenue over the trailing 12 months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.

Esperion Therapeutics, Inc. (ESPR) reported $80.1M in revenue in Q1 2026. This represents an increase of 23.2% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Esperion Therapeutics, Inc. (ESPR) reported on that line in every period on record.